Skip to main content
Log in

Ofloxacin and Erythromycin in the Management of Diffuse Panbronchiolitis

  • Poster Presentations
  • Respiratory Tract Infections — Bronchitis
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Homma H, Yamanaka A, Tanimoto S, Tamura M, Chijimatsu Y, et al. Diffuse panbronchiolitis. A disease entity of the transitional zone of the lung. Chest 83: 63, 1983

    CAS  Google Scholar 

  • Sato A, Hayakawa H, Okano A. Pathology and treatment of diffuse panbronchiolitis (DPB) accompanied by hyperplasia in bronchus-associated lymphoid tissue (BALT). Japanese Journal of Medicine 25: 391, 1986

    Google Scholar 

  • Yamamoto M, Kondo A, Tamura M, Izumi T, Ina Y, et al. Longterm therapeutic effects of erythromycin and new quinolone antibacterial agents on diffuse panbronchiolitis. Japanese Journal of Thoracic Diseases 28: 1305–1313, 1990

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sato, A., Hayakawa, H. & Suda, T. Ofloxacin and Erythromycin in the Management of Diffuse Panbronchiolitis. Drugs 45 (Suppl 3), 399–400 (1993). https://doi.org/10.2165/00003495-199300453-00172

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199300453-00172

Keywords

Navigation